English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The aims of the present study were to establish optimal doses and provide an alternate CO PD  for florfenicol against  Streptococcus suis  based on pharmacokinetic-pharmacodynamic integration modeling. The recommended dose (30 mg/kg b.w.) were administered in healthy pigs through intramuscular and intravenous routes for pharmacokinetic studies. The main pharmacokinetic parameters of  C  max , AUC 0-24h , AUC, Ke,  t  1/2ke , MRT,  T  max,  and Cl b , were estimated as 4.44 μg/ml, 88.85 μg⋅h/ml, 158.56 μg⋅h/ml, 0.048 h -1 , 14.46 h, 26.11 h, 4 h and 0.185 L/h⋅kg, respectively. The bioavailability of florfenicol was calculated to be 99.14% after I.M administration. A total of 124  Streptococcus suis  from most cities of China were isolated to determine the minimum inhibitory concentration (MIC) of florfenicol. The MIC 50  and MIC 90  were calculated as 1 and 2 μg/ml. A serotype 2  Streptococcus suis  (WH-2), with MIC value similar to MIC 90 , was selected as a representative for an  in vitro  and  ex vivo  pharmacodynamics study. The MIC values of WH-2 in TSB and plasma were 2 μg/ml, and the MBC/MIC ratios were 2 in TSB and plasma. The MPC was detected to be 3.2 μg/ml. According to inhibitory sigmoid  E  max  model, plasma AUC 0-24h /MIC values of florfenicol versus  Streptococcus suis  were 37.89, 44.02, and 46.42 h for the bactericidal, bacteriostatic, and elimination activity, respectively. Monte Carlo simulations the optimal doses for bactericidal, bacteriostatic, and elimination effects were calculated as 16.5, 19.17, and 20.14 mg/kg b.w. for 50% target attainment rates (TAR), and 21.55, 25.02, and 26.85 mg/kg b.w. for 90% TAR, respectively. The PK-PD cutoff value (CO PD ) analyzed from MCS for florfenicol against  Streptococcus suis  was 1 μg/ml which could provide a sensitivity cutoff value. These results contributed an optimized alternative to clinical veterinary medicine and showed that the dose of 25.02 mg/kg florfenicol for 24 h could have a bactericidal action against  Streptococcus suis  after I.M administration. However, it should be validated in clinical practice in the future investigations.

PK-PD Integration Modeling and Cutoff Value of Florfenicol against Streptococcus suis in Pigs